Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander D Boiko

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 18, 2013
Isolation of melanoma tumor-initiating cells from surgical tissuesAlexander D Boiko
Experimental Dermatology|April 11, 2016
Therapeutic implications of melanoma heterogeneityStephanie J Hachey, Alexander D Boiko
Methods in Molecular Biology (Clifton, N.J.)|April 17, 2016
Profiling Melanoma Heterogeneity Using Microwell RNA CytometryIvan K Dimov, Alexander D Boiko
Scientific Reports|May 24, 2019
CD271 is a molecular switch with divergent roles in melanoma and melanocyte developmentFabian V Filipp, Chen Li, Alexander D Boiko
Genes & Development|November 19, 2002
Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescenceXianghong Zou, Dipankar Ray, Aileen Aziyu, et al.
Plos Biology|October 1, 2019
Calreticulin is a Critical Cell Survival Factor in Malignant NeoplasmsArum Han, Chen Li, Tara Zahed, et al.
Genes & Development|January 19, 2006
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformationAlexander D Boiko, Sarah Porteous, Olga V Razorenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2019
Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signalingChen Li, Vincent Nguyen, Kaitlyn N Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cellsTao Lu, Lyudmila G Burdelya, Shannon M Swiatkowski, et al.
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 18, 2013
Isolation of melanoma tumor-initiating cells from surgical tissuesAlexander D Boiko
Experimental Dermatology|April 11, 2016
Therapeutic implications of melanoma heterogeneityStephanie J Hachey, Alexander D Boiko
Methods in Molecular Biology (Clifton, N.J.)|April 17, 2016
Profiling Melanoma Heterogeneity Using Microwell RNA CytometryIvan K Dimov, Alexander D Boiko
Scientific Reports|May 24, 2019
CD271 is a molecular switch with divergent roles in melanoma and melanocyte developmentFabian V Filipp, Chen Li, Alexander D Boiko
Genes & Development|November 19, 2002
Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescenceXianghong Zou, Dipankar Ray, Aileen Aziyu, et al.
Plos Biology|October 1, 2019
Calreticulin is a Critical Cell Survival Factor in Malignant NeoplasmsArum Han, Chen Li, Tara Zahed, et al.
Genes & Development|January 19, 2006
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformationAlexander D Boiko, Sarah Porteous, Olga V Razorenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2019
Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signalingChen Li, Vincent Nguyen, Kaitlyn N Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cellsTao Lu, Lyudmila G Burdelya, Shannon M Swiatkowski, et al.
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Pageof 2